Key result
Obesity accounts for ~70% of hypertension cases in obese patients.
Why the study?
Hypertension is a major complication of obesity, but the pathophysiologic factors of obesity-related hypertension and its therapeutic options remain not well understood.
This review summarizes the pathophysiology and treatment options for obesity-related hypertension, a major complication affecting about 70% of obese subjects.
Alerts clinicians to obesity's major role in hypertension; leaves open precise mechanisms and optimal therapies.
The prevalence of overweight and obesity has increased significantly in the United States and worldwide. Among the many complications of obesity, hypertension is the most common and major one accounting for about 70% in the obese subjects. However, the pathophysiologic factors of obesity-related hypertension and its therapeutic options are not well understood at present. To better understand the pathophysiology of obesity-related hypertension and its treatment options, a Medline search of the English language literature was contacted between 2010 and 2018 and 22 pertinent papers were selected. The information from these papers together with collateral literature will be discussed in this review.
No takes yet. Share an insight, caveat, or question.
Steven G. Chrysant (2019) conducted a review in Obesity-related hypertension. Obesity-related hypertension accounts for about 70% of hypertension in obese subjects, with its pathophysiology and therapeutic options discussed in a review of 22 papers.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: